Disclosure statement
Aaron Rosenberg served as an advisor for adaptive Bio, and has participated in Speakers bureau for Takeda and Janssen.
Brian A Jonas served as a consultant/advisor for AbbVie, Amgen, BMS, Celgene, Genentech, GlycoMimetics, Jazz, Pfizer, Takeda, Tolero, and Treadwell, received travel reimbursement from AbbVie, and received research funding to his institution from 47, AbbVie, Accelerated Medical Diagnostics, Amgen, AROG, Celgene, Daiichi Sankyo, F. Hoffmann-La Roche, Forma, Genentech/Roche, Gilead, GlycoMimetics, Hanmi, Immune-Onc, Incyte, Jazz, Loxo Oncology, LP Therapeutics, Pfizer, Pharmacyclics, Sigma Tau, and Treadwell.
Mehrdad Abedi served as an advisor for Celgene and participated in Speakers Bureaus for BMS, Gilead, Seattle genetics, and Abbvie.
Joseph M Tuscano received research support from Genentech, Pharmacyclics, AbbVie, BMS, Acrotech, Seattle Genetics, and Takeda.
The remaining authors have no conflicts of interest to disclose.